AI Driven Precision Medicine Platform for Canine Cancer

Fighting cancer on
both ends of the leash

FidoCure patient results are published and validated

FidoCure has sequenced, treated, and collected data from thousands of dogs and developed the largest proprietary cancer data set in the world.​

FidoCure has sequenced, treated, and collected data from thousands of dogs and developed the largest proprietary cancer data set in the world.​

Clinics using FidoCure
0
Data points
0 B
Vet adoption (oncologists)
0 %

FidoCure has sequenced, treated, and collected data from thousands of dogs and developed the largest proprietary cancer data set in the world.​

FidoCure has sequenced, treated, and collected data from thousands of dogs and developed the largest proprietary cancer data set in the world.​

Clinics using FidoCure
0
Data points
0 B
Vet adoption (oncologists)
0 %

We are transforming canine cancer care through ongoing scientific research and innovation in therapeutic treatments.

Dog cancer research advances pursuit of drugs for humans and canines​

Published June 19, 2023 | Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans

Dog cancer research advances pursuit of drugs for humans and canines​

Published June 19, 2023 | Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans

Can Dogs and AI Fight Cancer?

This talk by CEO Christina K. Lopes explores how our learnings from transforming canine cancer care can inform how to transform cancer in humans-impacting both sides ofthe leash.

There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.

FidoCure® Approach: Genetic testing reveals which targeted therapies may work best for your dog

Precision medicine can offer a hopeful prognosis.  FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible.  Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.

Forrest was diagnosed with splenic cancer and given one month to live.

Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.

“Thank you for your support and for opening the door to those four wonderful extra years.”
— Grace , CT

Forrest, Golden Retriever

Hemophagocytic Histiocytic Sarcoma

Thousands of dogs have benefited from FidoCure's AI driven approach when traditional treatments were limited

Real-World Evidence
Resources + Education

As Seen On: